S. 3974 — Introduced in Senate

II 117th CONGRESS 2d Session S. 3974 IN THE SENATE OF THE UNITED STATES March 31, 2022Mr. Cruz introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions A BILL To prohibit the consideration of patients' race, color, religion, sex, national origin, age, disability, vaccination status, veteran status, or political ideology or speech in determining eligibility for monoclonal antibody doses distributed by the Federal Government. 1. Short title This Act may be cited as the Ending Discrimination in COVID–19 Treatments Act. 2. Eligibility to receive monoclonal antibody treatment The Secretary of Health and Human Services shall require States, as a condition for receipt of monoclonal antibody doses from the Federal Government, to ensure that providers receiving distributions of such monoclonal antibody doses from such States do not take into consideration the race, color, religion, sex, national origin, age, disability, vaccination status, veteran status, or political ideology or speech of a patient in determining whether a patient is eligible to receive such treatment.